Inverse association between gastroesophageal reflux and blood pressure: Results of a large community based study

被引:3
作者
Murray, Liam J. [2 ]
McCarron, Peter [2 ]
McCorry, Roger B. [1 ]
Anderson, Lesley A. [2 ]
Lane, Athene J. [3 ]
Johnston, Brian T. [4 ]
Smith, George Davey [3 ]
Harvey, Richard F. [5 ]
机构
[1] Bolton Hosp NHS Trust, Bolton, England
[2] Queens Univ Belfast, No Ireland Canc Registry, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland
[3] Univ Bristol, Dept Social Med, Bristol, Avon, England
[4] Royal Hosp Trust, Belfast, Antrim, North Ireland
[5] Frenchay Hosp, N Bristol NHS Trust, Bristol BS16 1LE, Avon, England
关键词
D O I
10.1186/1471-230X-8-10
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: In a cross-sectional community based study, as part of a randomised controlled trial of eradication of Helicobacter pylori infection, the association between blood pressure and symptoms of gastro-oesophageal reflux was examined. Methods: Linear regression was used to examine the association between systolic and diastolic blood pressure and the frequency of heartburn and acid regurgitation in 4,902 of 10,537 participants aged 20-59 years. Results: In multivariable analyses, adjusted mean systolic blood pressure was 4.2 (95% confidence interval 1.5 to 7.0) mm Hg lower in participants with daily acid regurgitation compared to those with less frequent symptoms. Similarly, for diastolic blood pressure, a reduction of 2.1 (0.0 to 4.3) mm Hg wasobserved. Conclusion: People who experience daily symptoms of gastro-oesophageal reflux have lower blood pressure than people with less frequent or no symptoms. It is possible that factors influencing nitric oxide concentrations both at the lower oesophageal sphincter and within the vasculature may be involved. This hypothesis requires confirmation. Trials registration number: ISRCTN44816925.
引用
收藏
页数:4
相关论文
共 9 条
[1]   Mortality in Barrett's oesophagus: results from a population based study [J].
Anderson, LA ;
Murray, LJ ;
Murphy, SJ ;
Fitzpatrick, DA ;
Johnston, BT ;
Watson, RGP ;
McCarron, P ;
Gavin, AT .
GUT, 2003, 52 (08) :1081-1084
[2]   Mortality study of 18 000 patients treated with omeprazole [J].
Bateman, DN ;
Colin-Jones, D ;
Hartz, S ;
Langman, M ;
Logan, RF ;
Mant, J ;
Murphy, M ;
Paterson, KR ;
Rowsell, R ;
Thomas, S ;
Vessey, M .
GUT, 2003, 52 (07) :942-946
[3]   Endogenous nitric oxide synthesis: Biological functions and pathophysiology [J].
Bredt, DS .
FREE RADICAL RESEARCH, 1999, 31 (06) :577-596
[4]   Decreased sympathetic inhibition in gastroesophageal reflux disease [J].
Campo, SMA ;
Capria, A ;
Antonucci, F ;
Martino, G ;
Ciamei, A ;
Rossini, PM ;
Bologna, E ;
Cannata, D .
CLINICAL AUTONOMIC RESEARCH, 2001, 11 (01) :45-51
[5]  
Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023
[6]   Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease [J].
Kassim, SK ;
El Touny, M ;
El Guinaidy, M ;
Abd El Moghni, M ;
Abd El Mohsen, A .
CLINICAL BIOCHEMISTRY, 2002, 35 (08) :641-646
[7]   The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms [J].
Kennedy, T ;
Jones, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) :1589-1594
[8]  
Konturek JW, 1997, J PHYSIOL PHARMACOL, V48, P201
[9]  
Tomita R, 2003, HEPATO-GASTROENTEROL, V50, P110